Epithalon (Epitalon): Longevity Research and the Telomere Connection
For laboratory and research use only. This article summarises published scientific research on Epithalon (Epitalon). Neurovia’s Epithalon is not intended for human consumption. See our disclaimer.
Epithalon (Epitalon): Longevity Research and the Telomere Connection
Epithalon — also spelled Epitalon — is a synthetic tetrapeptide that has attracted significant research interest in the context of ageing biology, telomere dynamics, and longevity science. Developed from research on the pineal gland protein Epithalamin, it has an extensive published research history originating from the St. Petersburg Institute of Bioregulation and Gerontology in Russia.
This article provides an evidence-based overview of Epithalon: its molecular identity, the published research landscape, its studied relationship with telomerase and telomere biology, and its supply format for laboratory use.
What Is Epithalon?
Epithalon (also written Epitalon) is a synthetic tetrapeptide — a peptide consisting of four amino acids. Its sequence is:
Ala-Glu-Asp-Gly (AEDG)
Molecular profile:
- Sequence: Ala-Glu-Asp-Gly
- Length: 4 amino acids
- Molecular weight: ~390 Da
- CAS Number: 307297-39-8
Epithalon was developed as a synthetic analogue of Epithalamin — a polypeptide fraction extracted from bovine pineal gland tissue that was studied by Vladimir Khavinson and colleagues beginning in the 1970s. The tetrapeptide AEDG was identified as the putative bioactive component of Epithalamin, and subsequent research shifted to studying the synthetic version (Epithalon) directly.
The research on Epithalon is predominantly from Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology, with publications spanning several decades in journals including Bulletin of Experimental Biology and Medicine, Neuroendocrinology Letters, and Annals of the New York Academy of Sciences.
The Pineal Gland Research Context
The pineal gland is a small endocrine gland in the brain that produces melatonin and plays a role in circadian rhythm regulation. Interest in the pineal gland’s role in ageing has a long history in gerontology research, stemming from early observations that pineal function declines with age and that pineal extracts appeared to have life-extending effects in early animal studies.
The original Epithalamin research — from which Epithalon was derived — was conducted in the context of this broader interest in pineal peptides and their potential role in regulating biological ageing processes.
Epithalamin and subsequently Epithalon were studied as potential “bioregulators” — peptides that might influence regulatory processes in ageing tissues. This theoretical framework, developed by Khavinson’s group, forms the scientific context for much of the published Epithalon research.
Epithalon and Telomere Research
The most cited aspect of Epithalon research concerns its studied relationship with telomere biology and telomerase activity.
Background: Telomeres and Ageing
Telomeres are protective caps at the ends of chromosomes, consisting of repetitive DNA sequences (TTAGGG in humans). They shorten with each cell division, and when telomeres reach a critical minimum length, cells enter a state of replicative senescence — they can no longer divide. This process is studied as one of the cellular mechanisms of biological ageing.
Telomerase is an enzyme that can extend telomere length by adding DNA repeats to chromosome ends. It is highly active in stem cells and germ cells but has limited activity in most somatic cells, contributing to the progressive telomere shortening observed with cellular ageing.
Published Research on Epithalon and Telomerase
Published research by Khavinson and colleagues has examined Epithalon’s studied effects on telomerase activity in cell culture models. A key publication — Khavinson et al., Bulletin of Experimental Biology and Medicine, 2003 — reported that Epithalon stimulated telomerase activity in human fetal fibroblasts in cell culture, associated with elongation of telomeres.
Subsequent published work has extended these findings in various cell culture and animal models, examining:
- Telomere length dynamics in cell culture with and without Epithalon treatment
- Replicative lifespan of cultured cells — studies examining whether Epithalon-treated cells maintained proliferative capacity for longer periods
- Gene expression related to telomere maintenance in Epithalon-treated cell cultures
It is important to note that cell culture findings on telomerase activation do not directly translate to anti-ageing effects in living organisms. The relationship between in vitro telomerase stimulation and in vivo ageing processes is complex and not fully established.
Animal Longevity Research
Beyond cell culture work, published research from Khavinson’s group and independent groups has examined Epithalon in animal longevity models:
Rodent studies — Published studies in mice and rats have examined survival curves, tumour incidence, and markers of biological ageing in animals treated with Epithalon over extended periods. Several publications report extended median lifespan in treated animals compared to controls in specific experimental conditions.
Drosophila studies — Some published research has examined Epithalon’s effects in fruit fly (Drosophila melanogaster) longevity models, which are commonly used in ageing biology research due to their short lifespan and genetic tractability.
These animal studies provide a broader context for the telomere research but, as with all preclinical findings, do not constitute evidence of equivalent effects in humans.
Epithalon and Melatonin Research
A related area of published research has examined Epithalon’s interaction with the pineal gland’s melatonin production in animal models. Some published studies have reported changes in melatonin secretion patterns in Epithalon-treated animals, consistent with the original hypothesis that Epithalon acts as a pineal bioregulator.
This research connects Epithalon to the broader literature on melatonin, circadian rhythms, and ageing biology — an active area of research with an independent and extensive published literature.
Supply Format for Research
the peptide is supplied for laboratory research in two formats by Neurovia:
- the compound (Epitalon) 50mg vial — lyophilised, high-quantity format for extended research
- this compound Capsules 1mg — oral research format
All supplied at 99% purity, third-party tested, with Certificate of Analysis available.
Storage: lyophilised at -20°C long-term; 2–8°C short-term. Once reconstituted, refrigerate and use within 4 weeks.
Further reading: peer-reviewed research on it (PubMed).
Frequently Asked Questions
What is the peptide (Epitalon) peptide?
the compound (also spelled Epitalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG). It was developed as a synthetic analogue of Epithalamin — a pineal gland peptide fraction studied by Russian gerontologist Vladimir Khavinson. It has been researched primarily in the context of telomere biology, longevity, and pineal gland function.
What is the research on this compound and telomeres?
Published research, primarily from Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology, has reported that it stimulates telomerase activity in human fetal fibroblast cell cultures, associated with telomere elongation. This research has been published in peer-reviewed journals and extended to various cell culture and animal models.
What is the difference between the peptide and Epithalamin?
Epithalamin is a polypeptide fraction extracted from bovine pineal gland tissue studied in the original Russian gerontology research. the compound is the synthetic tetrapeptide (AEDG) identified as the putative bioactive component of Epithalamin. Research peptide suppliers provide the synthetic this compound rather than the bovine extract.
What are it peptide studies?
Published the peptide studies include cell culture research on telomerase activation and telomere elongation, animal longevity studies examining lifespan and tumour incidence, and research on melatonin and pineal gland function. The majority of published work is from Khavinson’s group in St. Petersburg.
Is the compound the same as Epitalon?
Yes — this compound and Epitalon are two different transliterations of the same compound. The sequence is the same (Ala-Glu-Asp-Gly), and both names refer to the same synthetic tetrapeptide in the research literature.
How is it supplied for research?
the peptide is available for research as a lyophilised powder (50mg vial) or in capsule format (1mg). Neurovia supplies the compound at 99% purity with a third-party Certificate of Analysis available.
What is the relationship between this compound and the pineal gland?
it was derived from Epithalamin — a peptide fraction extracted from bovine pineal gland tissue. Published research has examined its studied effects on pineal function, including interactions with melatonin secretion in animal models. The original research hypothesis positions the peptide as a potential pineal “bioregulator.”
This article summarises published peer-reviewed research on the compound and is provided for informational purposes only. Neurovia’s this compound is supplied for laboratory research use only and is not intended for human consumption. Full disclaimer →